Susquehanna Fundamental Investments, LLC Obs Eva Sa Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.14 - $1.83 $16,128 - $210,816	-115,200 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.1 - $2.17 $21,010 - $41,447	-19,100 Reduced 14.22%	115,200 $174,000
Q4 2021 Feb 14, 2022	SELL	$1.99 - $3.1 $64,675 - $100,750	-32,500 Reduced 19.48%	134,300 $267,000
Q3 2021 Nov 15, 2021	BUY	$2.47 - $3.34 $357,903 - $483,966	144,900 Added 661.64%	166,800 $519,000
Q2 2021 Aug 11, 2021	BUY	$2.56 - $3.35 $56,064 - $73,365	21,900 New	21,900 $66,000

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.